4/A
Changes in Ownership
Korro Bio, Inc. Filed Acc 0000950170-23-032730
Chief Scientific Officer sold 1,384 shares at $0.34 ($471)
- Chief Scientific Officer acquired 150,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Loose Christopher R. · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-07-04 | Exercise or conversion : show line 1 in the form 10b5-1 | +150,000 | 200,050 | D | ||
| 2023-07-06 | Sale : show line 2 in the form 10b5-1 | −1,384 | $0.34 | $471 | 198,666 | D |
| Open-market sales · 1,384 sh · avg $0.34 · $471 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2023-07-04 | Exercise or conversion : show line 3 in the form 10b5-1 Restricted Stock Unit | −150,000 | 150,000 | 0 | D |
Loading xslF345X04/ownership.xml…